98%
921
2 minutes
20
Introduction: Socioeconomic determinants along with genetic status may affect fatality rate of COVID-19. We intend to investigate the adjusted effects of the HLA-DRB1 alleles and socioeconomic determinants including gross domestic product per capita (GDP cap) and health expenditure per capita (HE cap) in fatality of COVID-19 during the early phase of epidemic in a group of countries.
Methods: As an ecological study, early exposure to epidemics was defined as having more than 5000 confirmed cases of COVID-19 from 1 March 2020 to 1 April 2020. Poisson regression was used to report adjusted incidence rate ratio (IRR) for case fatality rate in this constant time period.
Results: Fourteen countries were eligible. Among the alleles, DR7 showed the strongest risk factor (IRR=112.535, P<0.001). Having GDP cap more than 40000$ or having HE cap more than 3000$ was a protecting factor (IRR=0.899, P<0.001, adjusted with allele DR7). Having GDP cap more than 40000$ along with having HE cap more than 3000$ was a protecting factor (IRR=0.471, P<0.001, adjusted with allele DR7).
Conclusion: Socioeconomic status of the countries may compensate the probable harmful effect of some HLA-DRB1 alleles. This conclusion was limited to a period that all the selected countries had almost similar governmental intervention.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.32394/pe.75.43 | DOI Listing |
J Safety Res
September 2025
Department of Environmental Health Sciences, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address:
Introduction: Researchers, whether working in wet-labs, dry-labs, clinical settings, or field environments, encounter various hazards. However, there has been limited study on the health and safety of academic researchers. This study aimed to investigate hazardous occupational exposures and safety among researchers in academic settings at a large U.
View Article and Find Full Text PDFInj Prev
September 2025
Biomedical Research Foundation, Dhaka, Bangladesh
Background: During the student-led mass uprising in Bangladesh in July 2024, over 1300 cases of eye injuries were reported, with several hundred resulting in permanent blindness. However, the broader aftermath-encompassing financial hardship, social exclusion and psychological trauma-remains largely unexplored.
Objective: To assess the psychological, social and financial consequences of ocular injuries among survivors of the July 2024 protests in Bangladesh.
BMJ Open
September 2025
Upstream Lab, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Unity Health Toronto, Toronto, Ontario, Canada
Objective: This study validates the previously tested Screening for Poverty And Related social determinants to improve Knowledge of and access to resources ('SPARK Tool') against comparison questions from well-established national surveys (Post Survey Questionnaire (PSQ)) to inform the development of a standardised tool to collect patients' demographic and social needs data in healthcare.
Design: Cross-sectional study.
Setting: Pan-Canadian study of participants from four Canadian provinces (SK, MB, ON and NL).
Brain Behav Immun
September 2025
Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology (BIST), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; Biomedical Research Networking Center for Rare Diseases (CIBERER), Barcelona 08003, Spain.
Treatment-resistant depression (TRD) is a severe condition characterized by chronic and recurrent depressive symptoms, leading to significant morbidity and a considerable socio-economic impact. Genetic and biological studies suggest that TRD is associated with distinct biological characteristics. In this study, we analysed whole-transcriptome differences in 293 patients with major depressive disorder (MDD) to compare TRD (N = 150) vs non-TRD (N = 143) cases.
View Article and Find Full Text PDFJ Affect Disord
September 2025
Robert-Koch Institute, Department of Epidemiology and Health Monitoring, Berlin, Germany.
Background: Depressive symptoms significantly increase physical morbidity, mortality, and healthcare demands, while chronic diseases can exacerbate depressive symptoms. This study aimed to: 1) determine the prevalence of depressive symptoms among individuals with and without chronic diseases; 2) compare the number of chronic diseases across age groups in those with and without depressive symptoms; and 3) analyze associations between depressive symptoms and chronic diseases, adjusting for sociodemographic, socioeconomic, lifestyle, and health-related variables.
Methods: In this cross-sectional study, data from 275,009 participants (126,642 men, 148,367 women) in the third wave of the European Health Interview Survey (2018-2020) across 30 European countries were analyzed.